We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Mindray Expands Lab Chemistry and Hematology Product Offerings

By LabMedica International staff writers
Posted on 12 May 2009
New lab chemistry and hematology analyzers were launched at Mindray (Shenzen, China) product conference in April 2009, which took place in Shenzen, China. More...
The products are intended to bridge the capabilities gap between mid- to high-output level labs.

The new BC-5300 and BC-5380 hematology analyzers are compact, economical, and free of daily maintenance. The analyzers require a 20-μl sampling volume, offer 5-part differentiation, and 27 measured parameters. Both analyzers use the impedance method for WBC, RBC, and PLT counting; feature semiconductor laser scatter combined with chemical dye method, and advanced flow cytometry. Also featured are whole blood and diluted counting modes, and the capability to flag abnormal samples. The analyzers process at a rate of 60 samples per hour. The BC-5380 features a 30-sample capacity autoloader and random access for improved walkaway automation, and close tube sampling functions. Throughput for closed tube sampling is 50 samples per hour.

The hematology analyzers include a local area network (LAN) port, come with user-friendly software featuring a variety of customizations for operations and reporting, have a data storage capacity for 40,000 results including graphical information, and support health level 7 (HL7) protocol.

The BS-380 Chemistry analyzer is a strategically positioned addition to the BS- family, has fully automated, discrete, random access functions for routine, STAT, urine and homogenous immunoassays. The chemistry analyzer can process 300 samples per hour.

The analyzer repertoire includes tests for proteins and immunoglobulins, nonprotein nitrogen, lipids, glucide, enzymes, electroloytes and minerals, and others. The sample tray has 75 positions, sample volume ranges from 2-45 μl stepped by 0.1 μl. The device comes with an optional internal barcode reader for sample and reagent programming. Reagents are held in a 2-8 ˚C-refrigerated compartment with 60 positions. The system features automatic dilution of abnormal samples, automatic probes cleaning, and 8-step autowashing. The optical system consists of Halogen-Tungsten lamp, with reversed optics grating photometry, and a range of 12 wavelengths from 340-800 nm.

The BS-380 includes support for RS-232 and bidirectional laboratory information systems (LIS) interface. The system displays real-time running status, and monitors reactions in real time.

According to the company, these products are in part the result of being responsive to customer feedback. Mr. Jie Liu, chief operating officer (COO) of Mindray said, "Mindray will continue to develop new products in the in vitro diagnostics field through continued focus on research and development.” "These [new] products elevate Mindray to the rank of a global player in the in vitro diagnostics field,” Mr. Liu added.

Mindray Medical International Limited is a leading developer, manufacturer, and marketer of medical devices in China with a significant and growing presence worldwide. Mindray offers a broad range of products across three primary business segments: patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems.

Related Links:

Mindray



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
All-in-One Molecular System
AIO M160
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.